Which of the following is not given for acute severe bronchial asthma: March 2011
Salbutamol
Terbutaline
Salmeterol
Methyl xanthine
Ans. C: Salmeterol Sho acting beta2 agonits are the agent of choice for acute severe asthma Long acting beta-2 agonists (LABAs), such as salmeterol and formoterol, with a duration of action of at least 12 hours, represent the first choice of add-on therapy. They have consistently been demonstrated to improve asthma control and reduce the frequency and severity of exacerbations when compared to increasing the dose of inhaled coicosteroids (ICS) alone